{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:28:54Z","timestamp":1761863334406},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.biologicals.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T13:16:13Z","timestamp":1403788573000},"page":"184-190","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Virus elimination during the recycling of chromatographic columns used during the manufacture of coagulation factors"],"prefix":"10.1016","volume":"42","author":[{"given":"Peter L.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2014.06.003_bib1","unstructured":"Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency. Guideline on plasma-derived medicinal products. EMA\/CHMP\/BWP\/706271\/2010."},{"key":"10.1016\/j.biologicals.2014.06.003_bib2","first-page":"199","article-title":"Chromatographic removal of viruses from plasma derivatives","volume":"81","author":"Burnouf","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2014.06.003_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01703243","article-title":"Ultrapure plasma factor VIII produced by anti-F VIIIc immunoaffinity chromatography and solvent\/detergent viral inactivation. Characterisation of the Method M process and Hemofil M antihemophilic factor (human)","volume":"63","author":"Griffith","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1016\/j.biologicals.2014.06.003_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00001721-199412000-00010","article-title":"Large-scale preparation and biochemical charactization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography","volume":"5","author":"Feldman","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.biologicals.2014.06.003_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2516.1995.tb00097.x","article-title":"Virological safety of the purified factor IX concentrate, Replenine","volume":"1","author":"Roberts","year":"1995","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2014.06.003_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biologicals.2007.08.001","article-title":"Viral clearance studies on new and used chromatography resins: critical review of a large dataset","volume":"36","author":"Kelley","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2014.06.003_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1045-1056(03)00035-6","article-title":"Manufacturing process of anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance","volume":"31","author":"Morrica","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2014.06.003_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.chroma.2008.07.094","article-title":"Robustness of virus removal by protein A chromatography is independent of media lifetime","volume":"1205","author":"Lute","year":"2008","journal-title":"J\u00a0Chromatogr A"},{"key":"10.1016\/j.biologicals.2014.06.003_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chroma.2004.09.072","article-title":"Impact of multiple re-use of anion-exchange chromatography media on virus removal","volume":"1069","author":"Norling","year":"2005","journal-title":"J\u00a0Chromatogr A"},{"key":"10.1016\/j.biologicals.2014.06.003_bib10","series-title":"Use of sodium hydroxide for cleaning and sanitizing chromatography media and systems","author":"GE Healthcare","year":"2009"},{"key":"10.1016\/j.biologicals.2014.06.003_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.biologicals.2007.02.005","article-title":"Virus inactivation by protein denaturants used in affinity chromatography","volume":"35","author":"Roberts","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2014.06.003_bib12","first-page":"147","article-title":"Viral safety of solvent-detergent treated blood products","volume":"81","author":"Horowitz","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2014.06.003_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.biologicals.2008.06.002","article-title":"Virus inactivation by solvent\/detergent treatment using Triton X-100 in a high purity factor VIII","volume":"36","author":"Roberts","year":"2008","journal-title":"Biologicals"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105614000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105614000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T03:27:40Z","timestamp":1538537260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105614000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1045105614000505"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2014.06.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus elimination during the recycling of chromatographic columns used during the manufacture of coagulation factors","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}